泄露
发表于 2025-3-26 23:35:24
http://reply.papertrans.cn/24/2400/239913/239913_31.png
VOC
发表于 2025-3-27 01:10:57
http://reply.papertrans.cn/24/2400/239913/239913_32.png
Diuretic
发表于 2025-3-27 05:45:15
,Zur Übertragbarkeit der Ergebnisse,ascular failure who have failed conventional management. It is a temporary support most commonly implemented as a bridge to organ function recovery or definitive intervention (e.g., congenital heart defect repair, ventricular assistant device implantation, or heart or lung transplant). Patients who
难理解
发表于 2025-3-27 13:05:58
,Zur Übertragbarkeit der Ergebnisse,in children, and the vast majority of the data is extrapolated from adult-based evidence. Of the many kidney diseases in children, TPE may be beneficial in a small number of diseases. These include glomerular disease with a rapidly progressive form, such as ANCA-associated rapidly progressive glomer
注意力集中
发表于 2025-3-27 13:42:03
http://reply.papertrans.cn/24/2400/239913/239913_35.png
禁令
发表于 2025-3-27 19:07:36
Josef Krautkrämer,Herbert Krautkrämers paper published in 2009 by the European Pediatric Study Group in 2009, there have been four prospective trials and multiple case reports on effective terminal blockade with Eculizumab, an international consensus on the diagnostic and therapeutic strategies for management has been published in 2015
Organization
发表于 2025-3-28 00:54:34
https://doi.org/10.1007/978-981-13-2276-1Pediatric intensive care; Acute kidney injury; Hemolytic uremic syndrome; SLED and hybrid therapies; CRR
柱廊
发表于 2025-3-28 04:08:05
Springer Nature Singapore Pte Ltd. 2019
Halfhearted
发表于 2025-3-28 10:01:19
Plasmapheresis in Pediatric Renal Diseaseatients, including securing adequate vascular access, maintaining desired intravascular volume and circulating red cell mass, and preventing complications by early recognition of adverse reactions. Clinical applications of plasmapheresis in pediatric patients with renal diseases are discussed on the
febrile
发表于 2025-3-28 10:43:07
,Zur Übertragbarkeit der Ergebnisse,atients, including securing adequate vascular access, maintaining desired intravascular volume and circulating red cell mass, and preventing complications by early recognition of adverse reactions. Clinical applications of plasmapheresis in pediatric patients with renal diseases are discussed on the